The Supreme Court closed the misleading advertisements case against Patanjali, observing that once manufacturing of a product is permitted, its advertisement becomes a natural business practice, providing relief to the company after months of legal scrutiny.
Today, On 7th March, The Supreme Court is set to issue comprehensive directions for enforcing the Drugs and Magic Remedies Act. The case stems from a writ petition by the Indian Medical Association (IMA). The IMA seeks action against misleading advertisements promoting allopathic medicines. The ruling aims to curb false medical claims and protect public health.
Dabur filed a lawsuit against Patanjali, co-founded by Baba Ramdev, over claims made in an advertisement for chyawanprash. Dabur alleges that the ad includes misleading statements about the herbs used and product safety. The case is being heard in the Delhi High Court. The dispute highlights the ongoing rivalry between the two major Ayurvedic product brands.
![[Patanjali Controversy] Delhi HC Petition Alleges Non-Veg Ingredients in 'Tooth Powder' Labeled as Vegetarian](https://i0.wp.com/lawchakra.in/wp-content/uploads/2024/08/image-90-3.png?resize=447%2C367&ssl=1)
Today, On 30th August, Baba Ramdev and Patanjali face legal challenges over Divya Dant Manjan tooth powder labeled as vegetarian, but allegedly containing non-vegetarian cuttlefish. The Delhi High Court issued notices, and the next hearing is on November 28. This adds to previous legal issues, including deceptive advertising and safety concerns. Patanjali has faced multiple legal challenges over the years.
Today (23rd April):The Supreme Court criticized the Indian Medical Association (IMA) for prescribing expensive and unnecessary medicines, urging the IMA to rectify its internal issues and uphold ethical standards. The court emphasized close scrutiny of cases where the IMA endorses costly treatments and directed licensing authorities and the IMA to be involved in a case addressing misleading health claims.
